💊European Medicines Agency Validates Bristol-Myers Squibb’s Type II Variation Application for Opdivo (nivolumab) for Treatment of Patients with Resected High-Risk Advanced Melanoma Wednesday November 1st, 2017By Tokio X'press Pharmaceutical ONO
🎗Myanmar’s first full-scale hot-dip galvanizing and color steel sheet business for building materials started Wednesday November 1st, 2017By Tokio X'press steel JFE Steel
⚙Nidec Completes Acquisition of SV Probe Pte. Ltd., a Probe Card Manufacturer Wednesday November 1st, 2017By Tokio X'press precision Nidec
🏘Trial operation of “nationwide version vacant house / vacant land bank” Wednesday November 1st, 2017By Tokio X'press Real Estate MLIT
📉Delaware Chapter 11 Filing – M&G USA Corporation 📉Delaware Chap Wednesday November 1st, 2017By Tokio X'press Bankruptcy, Soverign Chapter 11
